The UCSC Genome Browser database: 2021 update is a dataset published in Nucleic Acids Research (2020). On theSindex it has a DataRank of 6.2, placing it in the top 3.1% of the data-sharing corpus. It has been cited 645 times, with 100 citing works in its 1-hop citation network. Its calibrated FAIR score is 84/100.
Ranks in the top 3% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
This score predates the current agent — it came from the earlier rubric, which blended repository metadata into the number and asked the model for a rating rather than an evidenced verdict. Re-evaluate the paper to score it against the current standards-anchored criteria, where every verdict is backed by a quote from the full text.
DOI present
datacite=25, pmcid=True, pmid=True
OpenAlex id present
files/OA location present but not flagged OA
15 OA location(s)
linked_datasets=25, datacite=25
accessions=1, trials=0
open license (cc-by)
downloads=0
no version chain
is_dataset
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.971
From this paper's citation signal
Citation Network Contribution
5.3
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Human Genome Research Institute
Grant: 5U41HG002371
National Human Genome Research Institute
Grant: 5U41HG007234
National Human Genome Research Institute
Grant: 5R01HG008742
National Human Genome Research Institute
Grant: 1U41HG010972
National Human Genome Research Institute
Grant: 5R01HG010329
National Institutes of Health
Grant: U01MH114825
Howard Hughes Medical Institute
Grant: 090100
Silicon Valley Community Foundation
Grant: 2017-171531
Silicon Valley Community Foundation
Grant: 2018-194093
California Institute for Regenerative Medicine
Grant: GC1R-06673-C
Center for Information Technology Research in the Interest of Society
Grant: 2020-0000000026
University of California Office of the President Emergency
Grant: R00RG2456
NHGRI NIH HHS
Grant: R01 HG008742
NHGRI NIH HHS
Grant: U41 HG010972
NHGRI NIH HHS
Grant: R01 HG010329
NHGRI NIH HHS
Grant: U41 HG007234
NHGRI NIH HHS
Grant: U01 HG010971
NHGRI NIH HHS
Grant: U41 HG002371
National Institutes of Health
Grant: 5U41HG007234-08
GENCODE: comprehensive genome annotation for human and mouse
National Institutes of Health
Grant: 5U01MH114825-03
A Cellular Resolution Census of the Developing Human Brain
National Institutes of Health
Grant: 5U41HG002371-21
The UCSC Genome Browser
National Institutes of Health
Grant: 5R01HG008742-02
The 200 mammals project: sequencing genomes by a novel cost-effective method, yielding a high resolution annotation of the human genome.
National Institutes of Health
Grant: 5U41HG010972-02
The WashU-UCSC-EBI Human Genome Reference Center
National Institutes of Health
Grant: 1R01HG010329-01
Evolution of new regulatory networks via genetic arms races between KRAB zinc finger proteins and retrotransposons
UCSC Baskin Endowed Chair Funds
FWCI
35.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
Additional file 2 of Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
Additional file 1 of Variants in a cis-regulatory element of TBX1 in conotruncal heart defect patients impair GATA6-mediated transactivation
Additional file 1 of Variants in a cis-regulatory element of TBX1 in conotruncal heart defect patients impair GATA6-mediated transactivation
Additional file 2 of Variants in a cis-regulatory element of TBX1 in conotruncal heart defect patients impair GATA6-mediated transactivation
Additional file 2 of Variants in a cis-regulatory element of TBX1 in conotruncal heart defect patients impair GATA6-mediated transactivation
Additional file 2 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 2 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 3 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 3 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 4 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 4 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 6 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 6 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 7 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 7 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 8 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 8 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 9 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response
Additional file 9 of Model constructions of chemosensitivity and prognosis of high grade serous ovarian cancer based on evaluation of immune microenvironment and immune response